市場調查報告書
商品編碼
1384962
排卵檢測套組的全球市場規模、佔有率和行業趨勢分析報告:2023-2030 年依產品、通路和地區分類的展望和預測Global Ovulation Testing Kits Market Size, Share & Industry Trends Analysis Report By Product (Urine Ovulation Test, Digital Ovulation Test, and Saliva Ovulation Test), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030 |
預計到 2030 年,排卵檢測套組市場規模將達到 37 億美元,預測期內CAGR為 6.4%。 2022年市場規模為506,912,700輛,成長為4.8%(2019-2022年)。
大流行的最大影響之一是對家庭醫療產品(包括排卵檢測套組)的需求激增。由於封鎖和限制,許多人試圖限制前往醫療機構、診所和藥房。因此,人們越來越偏好家庭醫療保健解決方案,包括排卵檢測套組。因此,排卵檢測套組市場的銷售量大幅成長。同時,對於那些積極嘗試懷孕的人來說,隨著大流行期間最大限度地提高成功機會的重要性增加,排卵檢測套組的使用也有所增加。
然而,不準確的結果,例如誤報(在未發生時顯示排卵)和漏報(在發生 LH突波時未能檢測到)可能會導致使用者困惑和沮喪。這種不準確的情況可能會影響計劃生育配合措施並引發消費者的懷疑。排卵檢測套組的品質和一致性在品牌內部和品牌之間可能有所不同。不一致的結果可能會損害這些產品的聲譽並阻礙重複購買。使用者可能並不總是正確遵循說明,這可能會導致結果不準確。製造商必須透過提供清晰詳細的說明來解決潛在的用戶錯誤。然而,確保用戶始終遵循這些說明仍然是一個課題。
產品展望
依產品分類,市場分為尿液排卵檢測套組、數位排卵檢測套組和唾液排卵檢測套組。在2022年的市場中,數位排卵檢測套組獲得了很大的收益佔有率。數位排卵檢測套組的出現預計將為新興企業提供堅實的基礎,並幫助他們在市場上佔有一席之地。一些數位排卵檢測套組具有內建記憶體或連接到智慧型手機應用程式的能力,允許用戶隨著時間的推移追蹤他們的生育能力或深入了解月經週期。數位套件的這些功能預計將推動對這些創新套件的需求。此外,不斷變化的醫療保健監管環境正在為新進入者獲得這些機會創造有利條件。
配銷通路展望
依配銷通路,市場分為大賣場和超市、電子商務、藥局和藥局。 2022 年,電子商務部門在市場中佔了顯著的收益佔有率。該區隔市場的成長歸因於電子商務的普及,這使得零售電子商務網站的使用更加方便。網路存取的快速擴張和網路購物平台的日益普及進一步推動了這一趨勢。此外,多樣化的產品供應以及專業客戶服務負責人的支援和資訊也有望對該領域的市場成長產生積極影響。
區域展望
從區域來看,本報告對北美、歐洲、亞太地區和拉丁美洲/中東/非洲的市場進行了分析。 2022年,北美地區佔市場最大的收益佔有率。這可能是由於藍牙連接和智慧倒數功能等高級功能的出現,對排卵檢測套組的需求增加。美國有大量工薪階層人口,他們去看醫療保健提供者的時間往往有限,這有助於排卵檢測套組銷售的增加。這項因素進一步強化了區域市場。此外,製造商現在專注於開發新產品,這些新產品能夠以更實惠的價格分佈提供卓越的效果,同時確保輸出的簡單性和可靠性。
The Global Ovulation Testing Kits Market size is expected to reach $3.7 billion by 2030, rising at a market growth of 6.4% CAGR during the forecast period. In the year 2022, the market attained a volume of 5,06,912.7 thousand units, experiencing a growth of 4.8% (2019-2022).
Some advanced ovulation testing kits can connect to smartphones via Bluetooth or wireless. This connectivity enables real-time data transmission and the seamless integration of ovulation data into fertility apps. Therefore, the Digital Ovulation Test segment would acquire approximately 35% share of the market by 2030. Technological advancements have led to the development of smart algorithms that can predict ovulation more accurately based on a user's cycle history. These algorithms consider cycle length, LH surge patterns, and other relevant data points. High-tech ovulation testing kits can connect to Wi-Fi networks, allowing users to securely store and access their ovulation data. This element is particularly appealing to those who prioritize data privacy and security. Some ovulation testing kits offer customization options. Users can input their cycle data, such as cycle length, and receive more tailored predictions, making the kits suitable for a broader range of users. Some of the factors impacting the market are rising proportion of couples adopting delayed parenthood, rising incidence of fertility issues, and growing accuracy concerns regarding test results.
Delaying parenthood often goes hand in hand with increased fertility and reproductive health awareness. Many individuals and couples are well-informed about the potential challenges of conceiving as they age. This awareness has created a need for tools to help them understand and monitor their fertility more effectively. Delayed parenthood has led to a desire to make the most of the remaining fertile years. Ovulation testing kits offer a way to pinpoint the optimal time for conception. The rise in delayed parenthood has led to various educational initiatives and information sharing about fertility, family planning, and the use of ovulation testing kits. Additionally, Fertility issues, such as irregular menstrual cycles, endometriosis, polycystic ovary syndrome (PCOS), and male factor infertility, can make conception challenging. Couples facing these issues often use ovulation testing kits to help them track their fertile window more precisely. Ovulation testing kits are a valuable resource for couples struggling with fertility issues. Identifying the LH surge that precedes ovulation, these kits help couples time their intercourse effectively, increasing the likelihood of conception. The awareness of fertility challenges has led to a proactive approach to fertility management.
One of the most significant effects of the pandemic was a surge in demand for at-home medical products, including ovulation testing kits. With lockdowns and restrictions, many individuals sought to limit their visits to healthcare facilities, clinics, and pharmacies. This led to a higher preference for home-based healthcare solutions, including ovulation testing kits. As a result, the market for these kits experienced a notable boost in sales. On the other hand, for those actively trying to conceive, the heightened importance of maximizing their chances of success during the pandemic led to increased use of ovulation testing kits.
However, inaccurate results, such as false positives (indicating ovulation when it has not occurred) or false negatives (failing to detect an LH surge when it has occurred), can lead to confusion and frustration for users. These inaccuracies can affect family planning efforts and may contribute to consumer skepticism. The quality and consistency of ovulation testing kits can alter between and even within the same brand. Inconsistent results can undermine the reputation of these products and deter repeat purchases. Users may not always follow the instructions correctly, leading to inaccurate results. Manufacturers must address potential user errors by providing clear and detailed instructions. However, ensuring that users consistently follow these instructions remains a challenge.
Product Outlook
On the basis of product, the market is segmented into urine ovulation test, digital ovulation test, and saliva ovulation test. The digital ovulation test garnered a significant revenue share in the market in 2022. The emergence of digital ovulation test kits is anticipated to provide startups with a solid foundation that helps establish their presence in the market. Some digital ovulation tests have built-in memory or smartphone app connectivity, allowing users to track their fertility over time and gain insights into their menstrual cycles. Such features in digital kits are anticipated to increase the demand for these innovative kits. Furthermore, the evolving landscape of healthcare regulations creates favorable conditions for new entrants to gain access to these opportunities.
Distribution Channel Outlook
Based on distribution channel, the market is fragmented into hypermarkets & supermarkets, e-commerce, and pharmacies & drugstores. The e-commerce segment recorded a remarkable revenue share in the market in 2022. The segment's growth is attributed to the prevalence of COVID-19, which has made retail e-commerce websites more convenient to use. This trend is further attributed to the rapid expansion of Internet access and the increasing popularity of online shopping platforms. In addition, the availability of diverse product offerings and access to expert customer service personnel for support and information is expected to influence this segment's market growth positively.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region generated the largest revenue share in the market. This can be attributed to the increasing demand for ovulation test kits due to the availability of advanced features like Bluetooth connectivity and smart countdown functions. The presence of a working-class population in the United States contributes to the increase in unit sales of ovulation test kits, as they often have limited time to visit a healthcare provider. This factor further enhances the regional market. Moreover, manufacturers are currently focusing on developing new products that can deliver superior results at a more affordable price point while ensuring their outputs' simplicity and reliability.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AccuQuik Testkits (AdvaCare Pharma), Fairhaven Health, LLC, Equinox Biotech Co., Ltd., Wondfo Biotech Co., Ltd, Pregmate, SPD Swiss Precision Diagnostics GmbH, Proov, Roman Health Ventures Inc. (Ro), Premom (Easy@Home Fertility), and Piramal Enterprises Limited.
Market Segments covered in the Report:
By Product (Volume, Thousand Units, USD Million, 2019-2030)
By Distribution Channel (Volume, Thousand Units, USD Million, 2019-2030)
By Geography (Volume, Thousand Units, USD Million, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research